scandium has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korsak, A; Koumarianou, E; Mikolajczak, R; Pawlak, D | 1 |
1 other study(ies) available for scandium and Pancreatic Neoplasms
| Article | Year |
|---|---|
Comparison of receptor affinity of natSc-DOTA-TATE versus natGa-DOTA-TATE.
Topics: Animals; Chelating Agents; Gallium Radioisotopes; Inhibitory Concentration 50; Neoplasms, Experimental; Pancreatic Neoplasms; Positron-Emission Tomography; Radioisotopes; Rats; Receptors, Somatostatin; Scandium; Tissue Distribution | 2011 |